| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.015 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.015 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |